Published in
Elsevier, Annals of Oncology, 6(21), p. 1203-1210, 2010
Links
- ORCID
- ORCID
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
Journal article published in 2009 by
Y. L. Kasamon,
R. J. Jones,
R. A. Brodsky,
E. J. Fuchs,
W. Matsui 
,
L. Luznik,
J. D. Powell,
A. L. Blackford,
A. Goodrich,
C. D. Gocke,
R. A. Abrams,
R. F. Ambinder,
I. W. Flinn
,
L. Luznik,
J. D. Powell,
A. L. Blackford,
A. Goodrich,
C. D. Gocke,
R. A. Abrams,
R. F. Ambinder,
I. W. Flinn
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Background: Rituximab may improve transplant outcomes but may delay immunologic recovery.